Direct measurement of human glicentin in plasma by two-site immunoradiometric assay

Biomedical Research

Volumn 17, Issue 2, 1996, Pages 141-148

  Satoh, Takeya ^a   Iguchi, Kazuaki ^a   Mochizuki, Tohru ^a   Kurokawa, Nobuo ^b   Yanaihara, Chizuko ^b   Nagai, Kenji ^a   Iwata, Naohito ^c   Yanaihara, Noboru ^d  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c NISSHIN SEIFUN GROUP INC   (Japan)

^d Yanaihara Institute Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GASTROINTESTINAL HORMONE; GLICENTIN; IODINE 125; MONOCLONAL ANTIBODY;

ACCURACY; ARTICLE; CONTROLLED STUDY; GEL FILTRATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; ILEUM; IMMUNORADIOMETRIC ASSAY; MEASUREMENT; NORMAL HUMAN; RABBIT; TISSUE LEVEL; VARIANCE;

ORYCTOLAGUS CUNICULUS;

EID: 0029899095     PISSN: 03886107     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.17.141     Document Type: Article

References (23)

1. ASSAN R. and SLUSHER N. (1972) Structure/function and structure/immunoreactivity relationships of the glucagon molecule and related synthetic peptides. Diabetes 12, 843-855
2. BATAILLE D., TATEMOTO K., GESPACH C., JOUNVALL H., ROSSELIN G. and MUTT V. (1982) Isolation of glucagon 37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett. 146, 79-86
3. BELL G. I., SANCHEZ-PESCADOR K., LAYBOURN P. J. and NAJARIAN R. C. (1983) Exon duplication and divergence in the human preproglucagon gene. Nature 304, 368-371
4. BRYANT M. G., CHRISTOFIDES N. D., MOODY A. J. and BLOOM S. R. (1983) Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas. Endocrinology 112, 917-923
5. HEDING L. G. (1971) Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabelologia 7, 10-19
6. HEDING L. G., FRANDSEN E. K. and JACOBSEN H. (1976) Structure-function relationship: immunologic. Metabolism 25, Suppl., 1327-1329
7. HOLST J. J. (1983) Gut glucagon, enteroglucagon, gut glucagon-like immunoreactivity, glicentin-current status. Gastroenterology 84, 1602-1613
8. HOLST J. J., ØRSKOV C., VAGN NIELSEN O. and SCHWARTZ T. W. (1987) Truncated glucagon-like peptide-1, an insulin-releasing hormone from the distal gut. FEBS Lett. 211. 169-174
9. HUNTER W. M. and GREENWOOD F. C. (1962) Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194, 495-496
10. KREYMAN B., GHATEI M. A., WILLIAMS G. and BLOOM S. R. (1987) Glucagon-like peptide 1, 7-36, a physiological incretin in man. Lancet 2, 1300-1303
11. MARCO J., BAROJA I. M., DIAZ-FIERROS M., VILLANUENA M. L. and VALVERDE I. (1972) Relationship between insulin and gut glucagon-like immunoreactivity (GLI) secretion in normal and gastrectomized subjects. J. Clin. Endocrinol. 34, 188-191
12. MOCHIZUKI T., OHSHIMA K., TAKATSUKA N., SATO K., KAKUYAMA H., IGUCHI K. and YANAIHARA N. (1993) Total synthesis of human glicentin. In Peptide Chemistry (ed. YANAIHARA N.) Escom, Leiden, pp. 158-161
13. MOJSOV S., HEINRICH G. and WILSON I. B. (1986) Preproglucagon gene expression in pancreas and intestine diversities at the level of post-translational processing. J. Biol. Chem. 261, 11880-11889
14. MOJSOV J., WEIR G. C. and HABENER J. F. (1987) Insulinotropin: glucagon-like peptide 1(7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79, 616-619
15. MOODY A. J., JACOBSEN H. and SUNDBY F. (1978) Gastric glucagon and gut glucagon-like immunoreactants. In Gut Hormones (ed. BLOOM S. R.) Churchill Livingstone, Edinburgh, pp. 369-378
16. 27-glucagon: The development of radioimmunoassay for total glucagon-like immunoreactivity in human plasma. Endocrinol. Japon 28, 419-427
17. ØRSKOV C., HOLST J. J., POULSEN S. S. and KIRKEGAARD P. (1987) Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30, 874-881
18. SHIMA K., HIROTA M., NAKAMURA K. and KODAIRA T. (1986) The normal range of the plasma immunoreactive glucagon level during a 75 g glucose tolerance test. Diabetes Res. Clin. Practice 1, 265-271
19. SUNDBY F., JACOBSEN H. and MOODY A. J. (1976) Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity. Horm. Metab. Res. 8, 366-371
20. THIM L. and MOODY A. J. (1981) The primary structure of porcine glicentin (proglucagon). Regul. Pept. 2, 139-151
21. VAN REGENMORTEL M. H. V., BRIAND J. P., MULLER S. and PLAUE S. (1988) Synthetic polypeptides as antigens. In Laboratory Techniques in Biochemistry and Molecular Biology (ed. BURDON R. H. AND VAN KNIPPENBERG P. H.) Elsevier, Amsterdam, pp. 108-113
22. YANAIHARA C., MATSUMOTO T., NISHIDA T., UCHIDA S., KOBAYASHI A., MOODY A. J., ORCI L. and YANAIHARA N. (1984) Chemical approach to develop glicentin C-terminal specific radioimmunoassay. Biochemical Res. 5, Suppl., 19-32
23. YANAIHARA N., MOCHIZUKI T., SATOH T., IMAI S., SASAKI K., KAKUYAMA H., HOSOE H., TAKATSUKA N., IGUCHI K., LUO W. Q., KUROKAWA N. and YANAIHARA C. (1996) Synthesis and biochemical characterization of proglucagon-related peptides. Ann. NY Acad. Sci. (in press)